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 Abstract 
Glutamine enhances the exercise-induced expansion of the tricarboxylic acid 
intermediate pool.  The aim of the present study was to determine whether oral 
glutamine, alone or in combination with hyperoxia, influenced oxidative metabolism 
and cycle time-trial performance. 8 participants consumed either placebo or 
0.125g.kg body mass
-1
 of glutamine in 5 ml.kg body mass
-1
 placebo 1 h prior to 
exercise in normoxic (control & glutamine respectively) or hyperoxic (FiO2=50%; 
hyperoxia & hyperoxia and glutamine respectively) conditions.  Participants then 
cycled for 6 min at 70% 2oV
 max immediately before completing a brief high 
intensity time-trial (~ 4min) where a pre-determined volume of work was completed 
as fast as possible.  The increment in pulmonary oxygen uptake during the 
performance test ( 2oV
 , p=0.02) and exercise performance {243  7 (control) vs 
242  3 (glutamine) vs 231  3 (hyperoxia) vs 228  5 (hyperoxia and glutamine) 
s, p<0.01} were significantly improved in hyperoxic conditions.  There was some 
evidence that glutamine ingestion increased  2oV
  in normoxia, but not hyperoxia 
(interaction drink/FiO2, p=0.04) however there was no main effect or impact on 
performance.  Overall the present data show no effect of glutamine ingestion either 
alone or in combination with hyperoxia, and thus no limiting effect of the 
tricarboxylic acid intermediate pool size, on oxidative metabolism and 
performance during maximal exercise. 
 
 
 
 Introduction 
At the onset of exercise there is an increase in the tricarboxylic acid (TCA) 
intermediate pool size which has been suggested to facilitate increased oxidative 
ATP resynthesis (Sahlin, Katz, & Broberg, 1990; Wagenmakers, 1998).  Conversely 
dissociation between the TCA intermediate pool size and oxidative energy 
provision during exercise has been consistently demonstrated during sub-maximal 
exercise (Bruce et al., 2001; Gibala, Gonzalez-Alonso & Saltin, 2002a; Gibala, 
Peirce, Constantin-Teodosiu &  Greenhaff, 2002b; Dawson, Howarth, Tarnopolsky, 
Wong & Gibala, 2003; Howarth, LeBlanc, Heigenhauser & Gibala, 2004; Timmons, 
Constantin-Teodosiu, Poucher & Greenhaff, 2004; Dawson, Baker, Greenhaff & 
Gibala, 2005; Bangsbo, Gibala, Howart & Krustrup, 2006).  However, Gibala, 
MacLean, Graham & Saltin, (1998) demonstrate that as exercise intensity (and 
hence TCA cycle flux) increases there is a concomitant (though non-linear) 
increase in the TCA intermediate pool size.  Therefore it seems likely that only 
during maximal intensity exercise, once maximal TCA intermediate concentration 
has been reached, will the TCA intermediate pool size be limiting to TCA cycle 
flux and thus oxidative metabolism, (i.e. unchanging TCA intermediate pool size 
during requirement for increased TCA cycle flux).   
 
Dichloroacetate infusion results in near-maximal activation of the pyruvate 
dehydrogenase complex and stockpiling of acetyl-units. During the transition to 
subsequent moderate intensity exercise, dichloroacetate infusion  has consistently 
been shown to enhance the rate of increase of oxidative metabolism as indicated by a 
 reduction in phosphocreatine degradation and lactate accumulation (Timmons et al. 
1996; Timmons, Poucher, Constantin-Teodosiu, Macdonald & Greenhaff, 1997; 
Timmons et al. 1998a Timmons, Gustafsson, Sundberg, Jansson & Greenhaff, 
1998b; Howlett, Heigenhauser, Hultman, Hollidge-Horvat & Spriet, 1999a; Parolin 
et al. 2000; Roberts, Loxham, Poucher, Constantin-Teodosiu & Greenhaff, 2002).  
However during the transition to high intensity exercise dichloroacetate infusion 
appears to have no effect on oxidative metabolism (Savasi, Evans, Heigenhauser & 
Spriet, 2002; Howlett, Heigenhauser & Spriet, 1999b).  Furthermore, whilst 
dichloroacetate infusion reduced TCA intermediate content at rest (Constantin-
Teodosiu et al, 1999) the majority of studies show no effect of prior dichloroacetate 
infusion on the TCA intermediate pool during exercise (Gibala et al. 2002b; 
Timmons et al. 2004).  The study by Bansgbo et al. (2006) is the only study to 
demonstrate manipulation (reduction) of the TCA intermediate pool during 
exercise following dichloroacetate infusion; after 15 s of high intensity exercise the 
TCA intermediate pool was reduced following dichloroacetate infusion, compared 
to saline, with no effect on oxidative metabolism.  Importantly however, this effect 
on the TCA intermediate was not maintained after 3 min of exercise.  Taken 
together, studies utilising dichloroacetate infusion prior to high intensity exercise 
therefore show a limitation downstream of the pyruvate dehydrogenase complex, 
hence implicating the TCA intermediate and / or oxygen delivery as limiting 
factors during high intensity exercise.  Surprisingly there is a paucity of data relating 
to the possible role of the TCA intermediate in limiting oxidative metabolism 
during high intensity exercise.  However, in contrast to the study by Bangsbo  et al. 
 (2006), the rate of oxidative ATP production and power output were enhanced 
during severe intensity finger flexion exercise when 6 g.day
-1
 of a mixture 
containing 55g.l
-1
 of malate (the TCA intermediate making the largest contribution 
to the increase in TCA intermediate during exercise (Gibala, Tarnopolsky, & 
Graham, 1997) was consumed for 15 days (Bendahan et al. 2002). 
 
Glutamine ingestion enhances the exercise-induced increase in the TCA 
intermediate pool following 10 min of cycle exercise at 70% 2oV
 max (Bruce et al. 
2001), though this had no effect on substrate level phosphorylation after 10 min of 
exercise.  However no previous study has investigated the effects of glutamine 
ingestion during high intensity, whole body exercise.  Therefore the first aim of the 
present study was to determine whether glutamine ingestion (via an enhanced TCA 
intermediate pool expansion) improves oxidative metabolism and performance 
during maximal aerobic exercise.   
 
Relieving a limitation at the level of the TCA cycle may only expose other 
limitations (e.g. oxygen delivery, enzyme activation), which prevent enhancement of 
oxidative metabolism (Tschakovsky & Hughson, 1999; Gurd et al. 2006).  We 
therefore hypothesised that any glutamine-mediated enhancement of TCA cycle 
flux, and hence NADH & FADH production, would exacerbate the oxygen delivery 
limitation found during high intensity exercise (Linnarsson, Karlsson, Fagraeus & 
Saltin, 1974; Adams & Welch, 1980; Knight et al. 1993; Hogan, Richardson & 
Haseler, 1999; Richardson et al. 1999a; Richardson, Leigh, Wagner & Noyszewski, 
1999b; Linossier et al. 2000).  Therefore a second aim of this experiment was to 
 compare the separate and combined effects of glutamine supplementation and 
hyperoxia on performance and oxidative metabolism during maximal aerobic 
exercise. 
 
Method 
Participants 
Eight trained cyclists (age: 36.0  4 yrs; 2oV
 max: 4.6  0.2 l.min-1; WorkMax: 381 ± 
46 W; mass: 80.4 ± 4 kg) completed the four-trial study, which was approved by the 
local university ethical committee. 
 
Preliminary testing 
The pre-experimental procedures were employed to replicate the protocol of Bruce 
et al. (2001) in which oral glutamine was demonstrated to enhance the exercise-
induced expansion of the TCA intermediate pool.  Full details of preliminary 
testing and pre-experimental procedures can be found elsewhere (Marwood & 
Bowtell, 2007).  In brief, a submaximal test and a maximal ramp test to determine 
2oV
 max, were completed.  An incremental maximum workload (WorkMax) test was 
also completed to individually determine the volume of work for the time trial 
(Jeukendrup, Saris, Brouns, & Kester, 1996).  Prior to the main trials, a 
familiarisation trial was performed to reduce any possible learning effect across the 
four trials.  A separate unpublished study utilising the present exercise protocol 
examined performance across three identical trials; there was no significant 
improvement in performance across trials.  In addition, the 95% limits of agreement 
 between adjacent trials reduced from 15.6 s / 27.9 W (mean performance: 222 s / 
377 W) between trials 1 & 2 to 9.25 s / 17.0 W (mean performance: 222 s / 378 W) 
between trials 2 & 3, suggesting a reduction in the 95% limits of agreement 
between adjacent trials to ~ 4 % of overall performance after a single familiarisation 
trial.  Therefore we were confident that performance during the experimental trials 
was reliable and without a learning effect.  
 
Pre-experimental procedures 
Participants were instructed to consume their habitual diet and refrain from 
strenuous physical activity in the 48 h prior to each experiment.  On the evening 
before the experiment (day 1), participants completed 30 min cycling at 70% 
2oV

max.  The workload was then doubled and 3 * 50 s bursts of exercise were 
completed, separated by 2 min of rest.  Participants then cycled for a further 45 min 
at 70% 2oV

max.  This also ensured that blood lactate concentration was low at the 
end of exercise to minimise glycogen resynthesis from lactate during recovery.  The 
glycogen depleting protocol was designed to deplete both type I and type II muscle 
fibres of glycogen as validated by Vollestad et al. (1992).  Participants were free to 
drink water throughout exercise.  Following the glycogen depleting exercise, 
participants consumed a prescribed diet (identical for each trial), based on their 
habitual diet, but which provided only 30% carbohydrate.  This ensured that only 
limited muscle glycogen resynthesis occurred before the 2
nd
 day of the experiment, 
and that the magnitude of resynthesis, and hence pyruvate availability, were similar 
for each trial.  This design was employed to replicate the protocol of Bruce et al. 
 (2001) in which oral glutamine was demonstrated to enhance the exercise-induced 
expansion of the TCA intermediate pool. 
 
Experimental Design 
Participants completed four main trials: placebo & normoxia (CON), glutamine & 
normoxia (GLN), placebo and hyperoxia (HYP) and hyperoxia and glutamine 
(HPG).  Trials were allocated in a systematic rotation fashion with participants 
blind to the condition.  Each trial took place over the course of two days and trials 
were separated by 10 – 14 days. 
 
Experimental protocol 
Each experimental trial was completed across 2 days.  On the evening of day 1, 
participants undertook a glycogen depletion protocol (see above).  On the morning 
of day 2, participants arrived at the laboratory following an overnight fast and 
rested in the supine position.  A cannula was inserted into an antecubital vein and a 
resting blood sample was obtained.  Participants then consumed a drink containing 
either 5ml.kg body wt
 -1
 of placebo or 0.125g.kg body wt 
-1
 glutamine in 5ml.kg 
body wt 
-1
 of placebo and rested for 1 h before exercise commenced.  Ten min 
before exercise, participants positioned themselves on the ergometer and inspired 
either normoxic (room) air (FiO2 = 21%) or a hyperoxic gas mixture containing 50% 
oxygen and balanced nitrogen (FiO2 = 50%).  Exercise commenced from rest and 
consisted of cycling for 6 min at 70% 2oV
 max immediately before completing a 
fixed-work time-trial (equal to 4 min at 95%Wmax).  Participants received verbal 
 encouragement to perform maximally and were provided with standardised 
information relating to their progress in the time trial.  Participants were informed 
of the completion of each 10 kJ until 20 kJ remaining where they were informed of 
each kJ completed until the finish.  Following 30 min of stationary recovery from 
exercise, participants cycled for a further 5 min at 100 W, after which a tourniquet 
was immediately inflated (around the thigh interrogated by near infrared 
spectroscopy, see below) to 260mmHg for 1 minute and then quickly deflated.  
 
Pulmonary gas exchange & near infrared spectroscopy 
Breath by breath pulmonary oxygen uptake ( 2oV
 ) was measured throughout 
exercise; participants wore a nose-clip and breathed through a mouthpiece 
connected to a low inertia turbine volume transducer (Interface associates, USA) and 
mass spectrometer system (CaSE QP9000, Morgan Medical, UK) tuned to measure 
oxygen, carbon dioxide, nitrogen and argon.  Prior to each exercise test, the turbine 
was calibrated using a precision 3-litre calibration syringe (Hans Rudolph Inc., 
USA).  The system was calibrated prior to each trial using gases of known 
concentration spanning the range of anticipated fractional gas concentrations during 
each trial (normoxia: 15% O2,; hyperoxia: 40% O2,).  The inlet port of the 
mouthpiece was connected to a 250L Douglas bag which was continuously filled 
with a gas mixture containing 50% oxygen and balanced nitrogen from a pressurised 
cylinder.  In the normoxic trials the Douglas bag was by-passed and participants 
breathed room air.  Measurement of 2oV
  in hyperoxia is technically difficult due to 
potential problems with contamination with ambient air.  However, open circuit 
 systems such as that used in the present study appear to circumvent such problems 
and have been shown to be valid measures of 2oV
  in hyperoxia (Prieur et al. 1998).   
The present device utilises standard algorithms (Beaver, Lamarra & Wasserman, 
1981) which have been utilised in previous studies measuring 2oV
  in hyperoxia 
(Bell, Paterson, Kowalchuk & Cunningham, 1999; Wilkerson, Berger & Jones, 
2006).  Hence we were confident that our measurement of 2oV
  in hyperoxia was 
valid.   
 
Continuous, non-invasive measurements of muscle deoxygenation via the 
deoxyhaemoglobin signal (Hb) were made via near infrared spectroscopy (NIRO 
500, Hamamatsu, Japan) throughout rest and exercise periods (see Marwood & 
Bowtell, 2007 for full details of these procedures).  Muscle deoxyhaemoglobin data 
were normalised to the physiological range which inflation and release of a cuff (see 
above) around the interrogated thigh produced (%Hb), (Marwood & Bowtell, 2007). 
 
Blood analysis   
Venous blood samples (12 ml) were taken at rest (prior to placebo / glutamine 
ingestion), 30 min post ingestion, at the onset of submaximal exercise, at the onset 
and after 2 min and at termination of the time trial and after 3, 6, 10, 15, 20 min of 
recovery from the time trial.  Samples were immediately centrifuged at 13,000 rpm 
for 2 min, the supernatant collected, snap frozen in liquid nitrogen and stored at -
80C and later analysed for lactate and glucose by an automated colorimetric assay 
 (Cobas Mira, ABX Diagnostics) and for glutamine using standard colorimetric 
assays (Bergmeyer, 1974).   
 
Data analysis 
2oV
  and %Hb data are expressed as the increment from the mean value during the 
final minute of submaximal exercise ( 2oV
  & %Hb).   2oV  & %Hb data are also 
normalised against the increment in power output relative to submaximal exercise 
( 2oV
 /W and %Hb/W).  
 
Statistics   
Values are presented as mean  standard error of the mean (SE) with an n of 8 for 
near infrared spectroscopy data and performance, 7 for pulmonary variables and 6 
for blood variables (due to technical problems with pulmonary gas and blood 
sampling).  Data from the first 6 min of exercise have been presented elsewhere 
(Marwood & Bowtell, 2007).   
 
Time course dependent data were analysed by a 3 way ANOVA for repeated 
measures {drink (glutamine vs placebo) by inspired oxygen fraction (FiO2: 
hyperoxia vs normoxia) by time}.  All other data were analysed by a 2 way ANOVA 
for repeated measures {drink (glutamine vs placebo) by FiO2 (hyperoxia vs 
normoxia)}.  The specific location of any effect was identified using a pairwise 
analysis (t-test) corrected by a Sidak-based Holm step-down procedure for multiple 
comparisons. 
  
Results 
 
Time trial 
The average volume of work to be completed during the performance test was 86.8 
± 10.4 kJ.  Average time-trial power output was higher (5.7  2.1%) during 
hyperoxic conditions (average of two hyperoxic trials versus two normoxic trials) 
but glutamine supplementation had no effect, {358  20 (control) vs 357  17 
(glutamine) vs 374  18 (hyperoxia) vs 380  20 (hyperoxia and glutamine) W, 
main effect FiO2, p=0.002, figure 1}.  Time to complete the time-trial was 243  7 
(control) vs 242  3 (glutamine) vs 231  3 (hyperoxia) vs 228  5 (hyperoxia 
and glutamine) s (main effect FiO2, p=0.002). 
 
Pulmonary gas exchange 
Average 2oV
  in the final minute of steady state exercise was 3.48 ± 0.17 (control), 
3.68 ± 0.14 (glutamine), 3.65 ± 0.10 (hyperoxia) 3.43 ± 0.19 (hyperoxia and 
glutamine) l.min
-1
. 

 2oV
  was higher in hyperoxia compared to normoxia (main effect FiO2, p=0.02; 
figure 2).  There was also a significant drink / FiO2 interaction (p=0.04) showing that 
the effect of glutamine was different in hyperoxia compared to normoxia.  
Subsequent pairwise analysis revealed that 2oV
  was higher in the hyperoxia trial 
 versus control, but that following glutamine ingestion  2oV
  was no higher in the 
hyperoxic condition compared to normoxia.  These effects remained when  2oV
  was 
normalised for the increment in power output (figure 3). 
 
Near infrared spectroscopy 
%Hb & %Hb /W increased throughout exercise with no effect of glutamine 
ingestion or hyperoxia (main effect time, p<0.001; figures 4, 5).   
 
Plasma Glutamine 
At rest, plasma glutamine concentration was not different between trials {537 ± 43 
(control) vs 651 ± 64 (glutamine) vs 570 ± 35 (hyperoxia) vs 565 ± 48 (hyperoxia 
and glutamine) µmol.l
-1
}. Glutamine ingestion resulted in a 94% and 96% increase 
in plasma glutamine concentration 30 min post-consumption compared to pre-
ingestion but was unchanged in placebo trials {537  46 (control) vs 1261 ± 91 
(glutamine) vs 633  44 (hyperoxia) vs 1108 ± 64 (hyperoxia and glutamine) 
µmol.l
-1
, main effect drink, p<0.001, figure 6}.  Immediately prior to exercise, 
plasma glutamine concentration remained slightly elevated above pre-ingestion in 
the glutamine trials but was not different to the placebo trials.  In the placebo trials 
plasma glutamine concentration was not different from rest at any time and there 
was no difference in plasma glutamine concentration between the two placebo-trials 
(control vs hyperoxia) or between the two glutamine-trials (glutamine vs hyperoxia 
and glutamine) at any time. 
 
 Plasma lactate 
Plasma lactate concentration was not significantly different between trials and this 
remained the case when the data were re-calculated as the change from rest or 
normalised against power output (figure 7).  There was no difference in peak plasma 
lactate concentration {12.2 ± 1.8 (control) vs 10.6 ± 1.0 vs (glutamine) vs 10.2 ± 
1.4 (hyperoxia) vs 10.6 ± 1.1 (hyperoxia and glutamine) mmol.l
-1
, figure 7} but 
the time to the peak measured lactate concentration following the termination of 
exercise was significantly longer following glutamine supplementation {1.5 ± 0.7 
(control) vs 4.0 ± 1.0 vs (glutamine) vs 2.6 ± 0.5 (hyperoxia) vs 5.0 ± 1.0 
(hyperoxia and glutamine) min, main effect drink, p<0.001; figure 7}. 
 
Discussion  
This is the first study to assess oxidative metabolism and performance during high 
intensity exercise following augmentation of the normal exercise-induced expansion 
of the TCA intermediate pool.  Exercise was also conducted in hyperoxic 
conditions in order to blunt the anticipated oxygen delivery limitation found during 
high intensity exercise and thus maximise any potential effect of glutamine ingestion 
on oxidative metabolism.  The main finding of the present study was that time-trial 
performance was unaffected by glutamine ingestion, whether in normoxia or 
hyperoxia.  In contrast performance was enhanced by ~ 6% in hyperoxia, with a 
concomitant significant increase in  2oV
 .  Hyperoxia has previously been shown to 
result in enhanced performance during high intensity exercise (Linnarsson, et al. 
1974; Adams & Welch, 1980; Knight et al. 1993; Hogan et al. 1999; Richardson et 
 al. 1999a,b; Linossier et al. 2000).  The mechanism by which hyperoxia exerts this 
effect appears to be via facilitation of oxygen consumption compared to normoxic 
conditions, resulting in a delay before the accumulation of metabolic by-products 
(H
+
, AMP, IMP, Pi) to fatiguing levels (Linnarsson, et al. 1974; Adams & Welch, 
1980; Knight et al. 1993; Hogan et al. 1999; Linossier et al. 2000; Prieur et al. 2006)  
 
Glutamine ingestion conferred no main effect on any measured parameter.  
However, there was a drink/FiO2 interaction effect for both  2oV
  and  2oV /W, 
whereby in the placebo trials  2oV
  and  2oV /W were higher in hyperoxia than 
normoxia, but hyperoxia had no further effect in glutamine trials.  Therefore the 
augmentation of  2oV
  and  2oV /W by hyperoxia was not apparent in the 
glutamine-supplemented trials, suggesting a beneficial effect of glutamine ingestion 
in normoxic conditions.  However, there was no main effect of glutamine ingestion 
on these parameters, nor muscle deoxygenation or plasma lactate concentration.  
Therefore the weight of the evidence suggests that there was no effect of glutamine 
ingestion on oxidative metabolism or exercise performance. 
 
Glutamine ingestion was utilised as it has previously been demonstrated to result in 
an enhancement of the exercise-induced increase in the TCA intermediate pool size 
at the onset of exercise (Bruce et al. 2001).  The present experimental protocol was 
designed to replicate as closely as possible that of Bruce et al. (2001) whilst 
inserting a period of high intensity exercise.  The study by Bruce et al. (2001) 
demonstrated a glutamine-induced enhanced expansion of the TCA intermediate 
 pool after 10 min of exercise at 70% 2oV
 max.  The present study, in addition to 
employing identical pre-exercise procedures, utilised the same exercise duration but 
divided into 6 min of exercise at 70% 2oV
 max and a ~4 min time trial.  TCA 
intermediate pool size is increased 4-fold after only 5 min of cycle exercise at 70% 
2oV
 max (Gibala et al. 1997) but decreases between 10 and 15 min exercise (Gibala 
et al. 2002a). Hence the present protocol was designed to maximise TCA 
intermediate pool size throughout the period of the time-trial.  However a limitation 
of the present study is a lack of muscle TCA intermediate data, and no previous 
study has determined whether the glutamine-induced expansion of TCA 
intermediate pool is evident during higher intensity exercise.  Examination of figure 
6 shows a marked (94-96%) increase in plasma glutamine concentration 30 min 
post-ingestion, which persisted up to the onset of exercise (19% higher than pre-
ingestion).  This suggests that as shown previously (Hankard et al. 1995; Bruce et al. 
2001), a substantial amount of the ingested glutamine escaped utilisation by the 
splanchnic bed.  Elevated plasma glutamine concentration stimulates muscle 
glutamine uptake via the human muscle glutamine transporter, system N
m 
(Ahmed, 
Maxwell, Taylor, & Rennie, 1993).  Therefore the decrease in plasma glutamine 
concentration from 30 min post-ingestion to the onset of exercise suggests that a 
significant amount of glutamine entered the muscle (Varnier, Leese, Thompson, & 
Rennie, 1995).  Hence it is likely that in the present study glutamine ingestion 
resulted in an enhancement of the exercise-induced expansion of the TCA 
intermediate pool as in the Bruce et al. (2001) study.  Therefore the present results 
 suggest that the size of the TCA intermediate pool does not limit oxidative 
metabolism or performance during maximal aerobic performance. 
 
The lack of any effect of hyperoxia on plasma lactate concentration during maximal 
exercise was perhaps not surprising since a number of previous studies have found 
similar results (Linnarsson et al. 1974; Adams & Welch, 1980; Knight et al. 1993; 
Hogan et al. 1999; Linossier et al. 2000; Savasi et al. 2002) suggesting that whilst 
exercise performance is enhanced in hyperoxia, fatigue occurs at the same 
intracellular concentrations of potential fatiguing metabolites (H
+
, AMP, IMP, Pi).  
Conversely, in the present study when plasma lactate concentration was normalised 
for power output, there still remained no differences in plasma lactate concentration 
between trials.  However, plasma lactate concentration reflects the balance between 
efflux of lactate from the muscle and removal of lactate from the circulation by non-
exercising muscle and the liver. Therefore, conclusions with regard to oxidative 
metabolism based on alterations in plasma lactate concentrations should be treated 
with caution.  Indeed, the later peak plasma lactate concentration following 
glutamine ingestion in the present study demonstrates the many factors that may 
influence plasma lactate concentration (indeed it is possible that glutamine interferes 
with either the passive or active export of lactate from the muscle, via 
monocarboxylate transporter 1; Fei et al. 2000).  Furthermore, the reduction in 
lactate concentration in hyperoxia observed in previous studies during submaximal 
exercise is likely due to a reduction in muscle glycogenolysis (Stellingwerff et al. 
2005; Stellingwerff, LeBlanc, Hollidge, Heigenhauser & Spriet, 2006).  However 
 the glycogen depletion protocol employed in the present study may have reduced 
muscle glycogenolysis during exercise, thus blunting this effect (Hargreaves, 
McConell & Proietto, 1995).   
 
Summary 
The main finding of the present study was that glutamine ingestion, previously 
shown to result in an enhancement of the exercise-induced increase in the TCA 
intermediate pool size (Bruce et al. 2001), has no effect on performance during 
high intensity exercise.  In addition, despite some evidence to the contrary (i.e. 
hyperoxia did not increase  2oV
  and  2oV /W following glutamine ingestion, 
figures 2 and 3) on balance glutamine ingestion did not enhance pulmonary oxygen 
or muscle deoxygenation kinetics during the time trial.  In accordance with 
previous studies demonstrating no effect of the TCA intermediate pool size on 
oxidative metabolism during submaximal exercise (Bruce et al. 2001; Gibala et al. 
2002a,b; Dawson et al. 2003; Howarth et al. 2004; Timmons et al. 2004; Dawson et 
al. 2005) and intense (Bangsbo et al. 2006) exercise, the present results show no 
effect of glutamine ingestion, and thus no limiting effect of the TCA intermediate 
pool size, on oxidative metabolism and performance during maximal aerobic 
exercise.  
 
 Figure 1.  Power output during the time-trial.  Values are mean  SE.  There was a 
main effect of time (p<0.001) and of FiO2 (p=0.002).  + different to 1
st
 minute of the 
time-trial (all trials, main effect time: pairwise analysis, p<0.05);  # different to 
previous time point (all trials, main effect time: pairwise analysis, p<0.05). $ 
hyperoxia vs normoxia (main effect FiO2, pairwise analysis, p<0.05). 
 
Figure 2.   2oV
  during the time-trial.  Values are mean  SE.  There was a main 
effect of time (p<0.001) and of FiO2 (p=0.02).  There was also a significant drink / 
FiO2 interaction (p=0.04).  + different to 1
st
 minute of the time-trial (all trials, main 
effect time: pairwise analysis, p<0.05);  # different to previous time point (all trials, 
main effect time: pairwise analysis, p<0.05). $ HYP vs CON (interaction drink / 
FiO2: pairwise analysis, p<0.05).  
 
Figure 3.   2oV
 /W during the time-trial.  Values are mean  SE.  There was a main 
effect of time (p<0.01) and of FiO2 (p<0.05).  There was also a significant drink / 
FiO2 interaction (p=0.02).  + different to 1
st
 minute of the time-trial (main effect 
time: pairwise analysis, p<0.05);  $ HYP vs CON (interaction drink / FiO2: pairwise 
analysis, p<0.05). 
 
Figure 4.  %Hb during the time-trial.  Values are mean  SE.  There was a main 
effect of time for all trials (p<0.001).  # different to previous time point (main effect 
time: pairwise analysis, p<0.05).   
 
  Figure 5.  %Hb/W during the time-trial.  Values are mean  SE.  There was a 
main effect of time for all trials (p<0.001).  # different to previous time point (main 
effect time: pairwise analysis, p<0.05).   
 
Figure 6.  Plasma glutamine concentration at rest and during exercise.  Plasma 
glutamine concentration was higher following glutamine supplementation compared 
to placebo (main effect drink, p<0.001).  There was also a significant drink/time 
interaction (p<0.001).  *glutamine vs placebo supplementation (interaction 
drink/time: pairwise analysis, p<0.05); # higher than resting concentrations 
(glutamine supplemented trials only; interaction drink/time: pairwise analysis, 
p<0.05); $ lower than at end of exercise (glutamine trials only; interaction drink / 
time: pairwise analysis, p<0.05). 
 
Figure 7.  Plasma lactate concentration during and following the time-trial.  Values 
are mean  SE.  There was a main effect of time (p<0.001).  + different to 
submaximal exercise (main effect time: pairwise analysis, p<0.05); # different to 
previous time point (main effect time: pairwise analysis, p<0.05); $ time to peak 
lactate concentration longer following glutamine supplementation (main effect 
drink, P<0.001). 
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